Galectin Inhibitor (GR-MD-02) and Ipilimumab in Patients With Metastatic Melanoma

Name: Galectin Inhibitor (GR-MD-02) and Ipilimumab in Patients With Metastatic Melanoma
License: Public Domain

Providence Health & Services

ClinicalTrials.gov · Datasets · License: Public Domain

metastatic melanoma

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 261500
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.